Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Up-Regulation of PD-L1, IDO, and T _regs in the Melanoma Tumor Microenvironment Is Driven by CD8 ⁺ T Cells

1. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   MaqolaCAR-T cell therapy researchJournal of Hematology & Oncology20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000083

2. Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

   Qianqian Huang, Fan Tong, Jiantao Chen +5

   Sharh maqolaNanoplatforms for cancer theranosticsAdvanced Science20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.review-article.000021